These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33539357)

  • 61. The use of imperfect diagnostic tests had an impact on prevalence estimation.
    Ihorst G; Forster J; Petersen G; Werchau H; Rohwedder A; Schumacher M
    J Clin Epidemiol; 2007 Sep; 60(9):902-10. PubMed ID: 17689806
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests.
    Qu Y; Tan M; Kutner MH
    Biometrics; 1996 Sep; 52(3):797-810. PubMed ID: 8805757
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estimation of diagnostic test accuracy: A "Rule of Three" for data with repeated observations but without a gold standard.
    Walter SD
    Stat Med; 2021 Sep; 40(22):4815-4829. PubMed ID: 34161623
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessing diagnostic tests: how to correct for the combined effects of interpretation and reference standard.
    Omurtag A; Fenton AA
    PLoS One; 2012; 7(12):e52221. PubMed ID: 23300619
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identifiability of models for multiple diagnostic testing in the absence of a gold standard.
    Jones G; Johnson WO; Hanson TE; Christensen R
    Biometrics; 2010 Sep; 66(3):855-63. PubMed ID: 19764953
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modeling conditional dependence between diagnostic tests: a multiple latent variable model.
    Dendukuri N; Hadgu A; Wang L
    Stat Med; 2009 Feb; 28(3):441-61. PubMed ID: 19067379
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Imputation approaches for estimating diagnostic accuracy for multiple tests from partially verified designs.
    Albert PS
    Biometrics; 2007 Sep; 63(3):947-57. PubMed ID: 17825024
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Accounting for nonignorable verification bias in assessment of diagnostic tests.
    Kosinski AS; Barnhart HX
    Biometrics; 2003 Mar; 59(1):163-71. PubMed ID: 12762453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Understanding the effects of conditional dependence in research studies involving imperfect diagnostic tests.
    Wang Z; Dendukuri N; Joseph L
    Stat Med; 2017 Feb; 36(3):466-480. PubMed ID: 27730659
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing Diagnostic Tests II: Grading on a Curve.
    Jupiter DC
    J Foot Ankle Surg; 2015; 54(4):765-6. PubMed ID: 25977153
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bayesian latent class models to estimate diagnostic test accuracies of COVID-19 tests.
    Hartnack S; Eusebi P; Kostoulas P
    J Med Virol; 2021 Feb; 93(2):639-640. PubMed ID: 32770741
    [No Abstract]   [Full Text] [Related]  

  • 72. Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations.
    Paul M; Riebler A; Bachmann LM; Rue H; Held L
    Stat Med; 2010 May; 29(12):1325-39. PubMed ID: 20101670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rejoinder to "On the robustness of latent class models for diagnostic testing with no gold standard".
    Schofield MR; Maze MJ; Crump JA; Rubach MP; Galloway RL; Sharples KJ
    Stat Med; 2021 Sep; 40(22):4770-4771. PubMed ID: 34515367
    [No Abstract]   [Full Text] [Related]  

  • 74. Latent class modeling approaches for assessing diagnostic error without a gold standard: with applications to p53 immunohistochemical assays in bladder tumors.
    Albert PS; McShane LM; Shih JH;
    Biometrics; 2001 Jun; 57(2):610-9. PubMed ID: 11414591
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Study roadmap for high-throughput development of easy to use and affordable biomarkers as diagnostics for tropical diseases: a focus on malaria and schistosomiasis.
    Kassegne K; Zhang T; Chen SB; Xu B; Dang ZS; Deng WP; Abe EM; Shen HM; Hu W; Guyo TG; Nwaka S; Chen JH; Zhou XN
    Infect Dis Poverty; 2017 Oct; 6(1):130. PubMed ID: 28965490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiple imputation to correct for partial verification bias revisited.
    de Groot JA; Janssen KJ; Zwinderman AH; Moons KG; Reitsma JB
    Stat Med; 2008 Dec; 27(28):5880-9. PubMed ID: 18752256
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.
    Clements MN; Corstjens PLAM; Binder S; Campbell CH; de Dood CJ; Fenwick A; Harrison W; Kayugi D; King CH; Kornelis D; Ndayishimiye O; Ortu G; Lamine MS; Zivieri A; Colley DG; van Dam GJ
    Parasit Vectors; 2018 Feb; 11(1):111. PubMed ID: 29475457
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficient Noninferiority Testing Procedures for Simultaneously Assessing Sensitivity and Specificity of Two Diagnostic Tests.
    Shan G; Amei A; Young D
    Comput Math Methods Med; 2015; 2015():128930. PubMed ID: 26366190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. On ROC analysis with nonbinary reference standard.
    Shiu SY; Gatsonis C
    Biom J; 2012 Jul; 54(4):457-80. PubMed ID: 22641278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests.
    Dendukuri N; Joseph L
    Biometrics; 2001 Mar; 57(1):158-67. PubMed ID: 11252592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.